Log in
Enquire now
‌

Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT02158572
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT021585720
Health Conditions in Trial
‌
Healthy
0
Trial Recruitment Size
2,0320
Trial Sponsor
Agile Therapeutics
Agile Therapeutics
0
Clinical Trial Start Date
2014
0
Primary Completion Date
2016
0
Study Completion Date
2016
0
Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
AG200-150
Interventional Trial Phase
Phase 30
Official Name
A Single-arm, Open-label, Multicenter Phase 3 Study of the Contraceptive Efficacy, Safety and Tolerability of the AG200-15 Transdermal Contraceptive Delivery System (TCDS)0
Last Updated
May 6, 2020
0
Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary

Study of the efficacy of a contraceptive patch in 2100 healthy women for up to one year.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.